IRM vs MBX · P/E 136, rev $3.97B vs $1.98B cap
Iron Mountain Incorporated (IRM) versus MBX Biosciences, Inc. Common Stock (MBX) — a side-by-side from cached financials, not a winner call.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
MBX does not have a complete income-statement cache yet.
IRM currently screens at market cap $37.09B and trailing P/E 135.5. MBX currently screens at market cap $1.98B.
Not investment advice. Open the IRM and MBX stock pages for the full models.
Not investment advice.